Asthma treatment

http://www.healasthma.com past six monthsthe past twelve months Search Hint Use the source navigation bar below to quickly narrow or broaden your search by geographic area. – . FD (FAIR DISCLOSURE) WIRE – Theravance Inc. and GSK announce positive phase b results for once-daily fluticasone furoate in the treatment of asthma Conference Call – Final OPERATOR Good morning, ladies and gentlemen. At this time I’d like to welcome everyone to the Theravance conference call. During the presentation all participants will be in a listen-only mode. A question-and-answer session will follow the Company’s formal remarks. (Operator Instructions). I will repeat these instructions after management completes their prepared remarks. Today’s conference is being recorded. And now I would like to turn the call over to Mr…. . Sun Sentinel (Fort Lauderdale, FL) – NEW ASTHMA INHALERS Asthma inhalers with chlorofluorocarbon (CFC) propellant will no longer be sold as of Jan. , in favor of inhalers with environmentally safer hydrofluoroalkane (HFA). Health experts advise Read and follow directions with the new inhaler. Prime the unit. Breathe in mist slowly, hold for seconds. Rinse inhaler opening with warm water to prevent clogging.Consider using a spacer. Plastic chamber attaches to inhaler and turns the spray into a mist for easy, efficient inhalation. Cost … . Times Union, The (Albany, NY) – CHECKUP Free screening of ‘Under Our Skin’ A screening of the award-winning documentary “Under Our Skin” will be shown at p.m. Saturday, Jan. , at the Guilderland Public Library, Western Ave., Guilderland.Sponsored by District Chapter of the Empire State Lyme Disease Association, the documentary investigates Lyme disease, an emerging epidemic. Following the stories of patients and physicians as they battle for their lives and… . New York Times, The Warning Given on Use of Popular Asthma Drugs, but Debate Remains Two federal drug officials have concluded that asthma sufferers risk death if they continue to use four hugely popular asthma drugs — Advair, Symbicort, Serevent and Foradil. But the officials’ views are not universally shared within the government.The two officials, who work in the safety division of the Food and Drug Administration, wrote in an assessment on the agency’s Web site on Friday that asthma sufferers of all ages should no longer take the medicines. A… . FD (FAIR DISCLOSURE) WIRE – Theravance Inc. Conference Call to Announce Positive Phase b Results for LABA, ‘ in the Horizon Asthma Development Programme – Final OPERATOR Ladies and gentlemen, good morning. At this time, I would like to welcome everyone to the Theravance conference call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the Company’s formal remarks. (OPERATOR INSTRUCTIONS). Today’s conference is being recorded. And now I would like to turn the call over to Mr. Mike Aguiar, Senior Vice President and Chief Financial Officer. Please go ahead,… . EDGAR Online -K Glimpse (USA) – -K SCHERING PLOUGH CORP Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM -K CURRENT REPORT Pursuant to Section or (d) of the Securities Exchange Act of Date of Report (Date of earliest event reported) SCHERING-PLOUGH CORPORATION (Exact Name of Registrant as Specified in its Charter) New Jersey – - (State or Other Jurisdiction of (Commission File Number) (IRS Employer … . FD (FAIR DISCLOSURE) WIRE – Q Apria Healthcare Group Earnings Conference Call – Final OPERATOR Welcome to Apria Healthcare’s second quarter earnings conference call. This conference include statements regarding anticipated future developments that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of . Results differ materially as a result of the risk factors included if the company’s filings with the Securities and Exchange Commission and other factors over which the company has no control…. . FD (FAIR DISCLOSURE) WIRE – Event Brief of Q Apria Healthcare Group Earnings Conference Call – Final PARTICIPANTS . Larry Higby, Apria Healthcare Group, CEO . Chris Karkenny, Apria Healthcare Group, CFO . Michael Levitt, Analyst . Darren Lehrich, Deutsche Bank, Analyst . Eric Gommel, Stifel Nicolaus, Analyst . Ben Wang, MLP, Analyst OVERVIEW AHG reported YTD sales of . b and net income of . m or . per share. Q sales were m and net income was . m or . per share. Co. expects full-year EPS to be . – . . FINANCIAL DATA A. Key Data… . FD (FAIR DISCLOSURE) WIRE – Event Brief of Q Apria Healthcare Group Earnings Conference Call – Final PARTICIPANTS . Larry Higby, Apria Healthcare Group, CEO . Chris Karkenny, Apria Healthcare Group, CFO . Michael Levitt, Analyst . Darren Lehrich, Deutsche Bank, Analyst . Eric Gommel, Stifel Nicolaus, Analyst . Ben Wang, MLP, Analyst OVERVIEW AHG reported YTD sales of . b and net income of . m or . per share. Q sales were m and net income was . m or . per share. Co. expects full-year EPS to be . – . . FINANCIAL DATA A. Key Data… . FD (FAIR DISCLOSURE) WIRE – Q Apria Healthcare Group Earnings Conference Call – Final OPERATOR Welcome to Apria Healthcare’s second quarter earnings conference call. This conference include statements regarding anticipated future developments that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of . Results differ materially as a result of the risk factors included in the company’s filings with the Securities and Exchange Commission and other factors over which the company has no control…. –